LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

3 Hazardous Reasons To Steer Clear Of AstraZeneca plc

Royston Wild looks at why AstraZeneca plc (LON: AZN) is an exceptionally risky stock selection.

Read more »

Investing Articles

Can AstraZeneca plc Make £5 Billion Profit?

Will AstraZeneca plc (LON: AZN) be able to drive profits higher?

Read more »

Investing Articles

Is AstraZeneca plc Dependent On Debt?

Are debt levels at AstraZeneca plc (LON: AZN) becoming detrimental to its future prospects?

Read more »

Investing Articles

GlaxoSmithKline plc Vs AstraZeneca plc — Which Is The Better Bet For Income And Growth?

GlaxoSmithKline plc (LON:GSK) and AstraZeneca plc (LON:AZN) are both great companies, but which one should you choose?

Read more »

Investing Articles

David & Goliath: AstraZeneca versus Hikma Pharmaceuticals

Which company is most attractive, AstraZeneca or its smaller rival Hikma Pharmaceuticals?

Read more »

Company Comment

The Contrasting Fortunes Of AstraZeneca plc And GlaxoSmithKline plc

AstraZeneca plc's (LON: AZN) limp results place it in the shadow of rival GlaxoSmithKline plc (LON: GSK).

Read more »

Company Comment

AstraZeneca plc’s Profit Slashed By Half

Pre-tax profits fell 57% for AstraZeneca plc (LON: AZN) amid competition from copycat drugs.

Read more »

Investing Articles

Why I Sold AstraZeneca plc

For one Fool, it's time to take profits on AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

Eyes Down For AstraZeneca plc’s Results

It's time to see how 2013 went for AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

5 Ways AstraZeneca plc Could Make You Rich

Some investors gave up on AstraZeneca plc (LON: AZN) but history has proved them wrong, says Harvey Jones.

Read more »

Investing Articles

Does AstraZeneca plc Pass My Triple Yield Test?

Finding affordable stocks is getting difficult in today's buoyant market. Does AstraZeneca plc (LON:AZN) fit the bill?

Read more »

Investing Articles

What Are AstraZeneca plc’s Dividend Prospects Like Beyond 2014?

Royston Wild looks at the long-term payout potential of AstraZeneca plc (LON: AZN).

Read more »